Pacific Biosciences of California Inc
F:P09
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacific Biosciences of California Inc
F:P09
|
US |
|
S
|
Sumitomo Realty & Development Co Ltd
XMUN:RL2
|
JP |
|
M
|
Medifast Inc
XMUN:MDF
|
US |
Wall St Price Targets
P09 Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for P09 is 2.66 EUR with a low forecast of 1.61 EUR and a high forecast of 3.35 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is P09's stock price target?
Price Target
2.66
EUR
According to Wall Street analysts, the average 1-year price target for P09 is 2.66 EUR with a low forecast of 1.61 EUR and a high forecast of 3.35 EUR.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 28%.
